Mark Walker

39.7k citations

171 papers · 7.9k · 1 hit paper · h-index 51

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Management and Research
Genetics top 0.5%
- Genetic Associations and Epidemiology
- Diabetes and associated disorders

Papers in

Molecular Biology 51
- Metabolism, Diabetes, and Cancer 21
- Mitochondrial Function and Pathology 12
Endocrinology, Diabetes and Metabolism 31

Co-authors: Andrew T. Hattersley (41 shared papers)Mark I. McCarthy (41 shared papers)Timothy M. Frayling (32 shared papers)G. A. Hitman (35 shared papers)Audrey E. Brown (9 shared papers)Michael N. Weedon (16 shared papers)Douglass M. Turnbull (15 shared papers)Katharine R. Owen (16 shared papers)
Journals: Diabetes (25 papers)Diabetologia (24 papers)Diabetic Medicine (16 papers)The Journal of Clinical Endocrinology & Metabolism (8 papers)Investigative Ophthalmology & Visual Science (7 papers)
Partner nations: United Kingdom United States Denmark

In The Last Decade

Mark Walker

167 papers receiving 7.6k citations

Mark Walker's Hit Papers

align trajectories log scale

Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes 2003 · 586 citations

Peers

Countries citing papers authored by Mark Walker

Since Specialization

Citations

This map shows the geographic impact of Mark Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Walker more than expected).

Fields of papers citing papers by Mark Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Walker. The network helps show where Mark Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Walker Line = papers co-authored together Mark Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes Diabetes ·Anna L. Gloyn, Michael N. Weedon, Katharine R. Owen, Martina Turner, Bridget Knight, G. A. Hitman, Mark Walker, J Lévy, Mike Sampson, Stephanie Halford, Mark I. McCarthy, Andrew T. Hattersley, Timothy M. Frayling Hit paper breakdown →	2003	586
2	Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals Diabetologia ·(unknown), Francis Finucane, Jian’an Luan, Nicholas J. Wareham, Stephen J. Sharp, Stephen O’Rahilly, Beverley Balkau, Allan Flyvbjerg, Mark Walker, Kurt Højlund, John J. Nolan, David B. Savage	2009	261
3	Genetics of Insulin Resistance and the Metabolic Syndrome Current Cardiology Reports ·Audrey E. Brown, Mark Walker	2016	250
4	Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome Nature Genetics ·Tom Hearn, Glenn L. Renforth, C. Mirella Spalluto, Neil A. Hanley, Karen Piper Hanley, Sarah Brickwood, Chris White, V. Connolly, J F Taylor, Isabelle Russell‐Eggitt, Dominique Bonneau, Mark Walker, David I. Wilson	2002	233
5	Combining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction PLoS Medicine ·Michael N. Weedon, Mark I. McCarthy, G. A. Hitman, Mark Walker, Christopher J. Groves, Eleftheria Zeggini, Nigel W. Rayner, Beverley M. Shields, Katharine R. Owen, Andrew T. Hattersley, Timothy M. Frayling	2006	212
6	Association Analysis of 6,736 U.K. Subjects Provides Replication and Confirms TCF7L2 as a Type 2 Diabetes Susceptibility Gene With a Substantial Effect on Individual Risk Diabetes ·Christopher J. Groves, Eleftheria Zeggini, Jayne A.L. Minton, Timothy M. Frayling, Michael N. Weedon, Nigel W. Rayner, G. A. Hitman, Mark Walker, Steven Wiltshire, Andrew T. Hattersley, Mark I. McCarthy	2006	209
7	Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation Diabetic Medicine ·Rinki Murphy, Douglass M. Turnbull, Mark Walker, Andrew T. Hattersley	2008	198
8	Common Variants of the Novel Type 2 Diabetes GenesCDKAL1andHHEX/IDEAre Associated With Decreased Pancreatic β-Cell Function Diabetes ·Laura Pascoe, Andrea Tura, Sheila K. Patel, Ibrahim M. Ibrahim, Ele Ferrannini, Eleftheria Zeggini, Michael N. Weedon, Andrea Mari, Andrew T. Hattersley, Mark I. McCarthy, Timothy M. Frayling, Mark Walker	2007	195
9	Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes ·Stewart Huxtable, P. J. Saker, Lema Haddad, Mark Walker, Timothy M. Frayling, J Lévy, G. A. Hitman, Stephen O’Rahilly, Andrew T. Hattersley, Mark I. McCarthy	2000	154
10	Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications American Journal of Clinical Nutrition ·ME Daly, Catherine Vale, Mark Walker, Alberti Kg, John C. Mathers	1997	152
11	Insulin Resistance, Insulin Response, and Obesity as Indicators of Metabolic Risk The Journal of Clinical Endocrinology & Metabolism ·Ele Ferrannini, Beverley Balkau, Simon W. Coppack, Joost Dekker, Andrea Mari, John J. Nolan, Mark Walker, Andrea Natali, Henning Beck‐Nielsen	2007	147
12	Meta-Analysis and a Large Association Study Confirm a Role for Calpain-10 Variation in Type 2 Diabetes Susceptibility The American Journal of Human Genetics ·Michael N. Weedon, Peter E. H. Schwarz, Yukio Horikawa, Naoko Iwasaki, Thomas Illig, Rolf Holle, Wolfgang Rathmann, T. Selisko, Jan Schulze, Katherine R. Owen, Julie Evans, Laura del Bosque‐Plata, G. A. Hitman, Mark Walker, J Lévy, Mike Sampson, Graeme I. Bell, Mark I. McCarthy, Andrew T. Hattersley, Timothy M. Frayling	2003	146
13	The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and Objectives Diabetologia ·(unknown), S. A. Hills, Beverley Balkau, SW Coppack, Joost Dekker, Andrea Mari, Andrea Natali, Mark Walker, Ele Ferrannini	2004	141
14	Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes Diabetes ·Wendy Winckler, Michael N. Weedon, Robert Graham, Steven A. McCarroll, Shaun Purcell, Peter Almgren, (unknown), Daniel Gaudet, Kristina Bengtsson Boström, Mark Walker, G. A. Hitman, Andrew T. Hattersley, Mark I. McCarthy, Kristin Ardlie, Joel N. Hirschhorn, Mark J. Daly, Timothy M. Frayling, Leif Groop, David Altshuler	2007	140
15	Key Role for Ceramides in Mediating Insulin Resistance in Human Muscle Cells Journal of Biological Chemistry ·Laura Pickersgill, Gary J. Litherland, Andrew S. Greenberg, Mark Walker, Stephen J. Yeaman	2007	120
16	Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK BMC Public Health ·Linda Penn, Martin White, John Oldroyd, Mark Walker, K. G. M. M. Alberti, John C. Mathers	2009	119
17	Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT PLoS ONE ·Linda Penn, Martin White, Jaana Lindström, Annemieke Th. den Boer, Ellen E. Blaak, Johan G. Eriksson, Edith J. M. Feskens, Pirjo Ilanne‐Parikka, Sirkka Keinänen‐Kiukaanniemi, Mark Walker, John C. Mathers, Matti Uusitupa, Jaakko Tuomilehto	2013	102
18	Adiposity-Related Heterogeneity in Patterns of Type 2 Diabetes Susceptibility Observed in Genome-Wide Association Data Diabetes ·Nicholas J. Timpson, Cecilia M. Lindgren, Michael N. Weedon, Joshua C. Randall, Willem H. Ouwehand, David P. Strachan, Nigel W. Rayner, Mark Walker, G. A. Hitman, Alex S. F. Doney, (unknown), Andrew D. Morris, Andrew T. Hattersley, Eleftheria Zeggini, Timothy M. Frayling, Mark I. McCarthy	2008	100
19	Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance Diabetologia ·Christopher P. Day, Jane I. Grove, Ann K. Daly, M Stewart, Peter Avery, Mark Walker	1998	99
20	Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility American Journal of Obstetrics and Gynecology ·Graeme N. Smith, Mark Walker, Julie L. Tessier, Kenneth Millar	1997	98

About Mark Walker

Mark Walker is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Physiology, Genetics and Surgery, having authored 171 papers that have together received 7.9k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (22 papers), Metabolism, Diabetes, and Cancer (21 papers), Pancreatic function and diabetes (21 papers), Diabetes and associated disorders (13 papers), Diet and metabolism studies (13 papers), Mitochondrial Function and Pathology (12 papers), Ophthalmology and Eye Disorders (10 papers) and Genetic Associations and Epidemiology (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Genetics (2.1k citations), Physiology (1.3k citations), Clinical Biochemistry (359 citations) and Surgery (1.6k citations). Mark Walker has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Andrew T. Hattersley, Mark I. McCarthy, Timothy M. Frayling, G. A. Hitman, Audrey E. Brown, Michael N. Weedon, Douglass M. Turnbull, Katharine R. Owen, J Lévy and Mike Sampson. Their work appears in journals such as Diabetes, Diabetologia, Diabetic Medicine, The Journal of Clinical Endocrinology & Metabolism and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark Walker

Impact in

Papers in i

In The Last Decade

Mark Walker

Mark Walker's Hit Papers

Peers

Countries citing papers authored by Mark Walker

Fields of papers citing papers by Mark Walker

All Works

About Mark Walker

Explore authors with similar magnitude of impact

Papers in